For a boy with SMA in China, starting Evrysdi (risdiplam) just 12 days after birth was safe and helped him reach key motor ...

Yet over the month-long pilot study, "they were getting better and better." Spinal muscle atrophy or SMA is a genetic disease that gradually destroys motor neurons, nerve cells in the spinal cord ...

Public health activists estimate Roche earned significantly more from risdiplam, a spinal muscular atrophy drug, than its ...

The chance of someone being born with SMA is one in 6,400 ... we had severe scoliosis which caused us to have to get a spinal fusion. Unfortunately, one of the bad things about it is it stunted ...

Those with spinal muscular atrophy can get emotional support by building an SMA support system that includes SMA communities ...

Spinal muscular atrophy (SMA) treatment has evolved significantly with the introduction of disease-modifying therapies. In this exclusive Q&A, Julie Parsons, MD, professor of clinical pediatrics ...

Early diagnosis of Spinal Muscular Atrophy (SMA) allows healthcare professionals to implement appropriate strategies to manage the condition effectively. Let's understand the importance of ...

All money supports the researchers’ quest to find a treatment and cure. Spinal Muscular Atrophy (SMA) is a deadly, genetic disease that causes a dramatic loss of strength and, in most cases ...

Affordable generic version of SMA drug Risdiplam soon available in India, offering hope to patients and activists.

We can improve the quality of life for children affected by SMA and similar disorders ... Therapy When It Comes To Management Of Spinal Muscular Atrophy? Physical therapy (PT) and occupational ...